SANTA FE, N.M.--(BUSINESS WIRE)--Dorothy H. Bray, Ph.D., will chair the Scientific Advisory Board at CytoDyn, Inc. (OTCBB:CYDY), the Company announced today. Dr. Bray has garnered extensive experience in the development of drugs for HIV/AIDS while serving in various senior positions at GlaxoSmithKline (NYSE:GSK) and its predecessors, a leading provider of antiretroviral drugs.
